Many startups and established companies focused on drug testing on human data in preclinical studies have been boosted by FDA's move away from reliance on animal testing towards organoid, organ-on-a-chip, and other in silico technologies. A Connecticut startup believes whole-organ testing should be an essential part of this mix.
Check out new developments from Emulate, HealthMine, LuminDx, and more.
Healthcare payments are no longer about transactions. It’s about controlling the revenue cycle. And increasingly, that control is not sitting with ISOs.
Each Organ-Chip is a transparent, flexible microenvironment that contains two parallel chambers that can be configured to grow human cells from an organ of interest, such as the liver, kidney proximal tubule, intestine, lung and brain
Check out new developments from Kiio, HealthMine, Emulate and Bind Benefits.
Read about new developments from Emulate, Cellino, Heru and more.
Read about news from life science companies Emulate, Astrocyte Pharmaceuticals and Bone Health Technologies.
We'll explore why the next era of payer performance will depend on building a trusted data foundation that connects people, providers, and relationships across the enterprise.
Read news from healthcare startups including Outcomes4Me, Emulate, and more.
The hope is that the company’s liver chip will predict toxicity in humans better than current cell-based and animal models.
Emulate wants its technology to "operate as a plug-and-play system in the hands of product development teams at pharmaceutical, chemical, food and consumer products companies," CEO James Coon said in a statement.